APA

Kan N., Okino T., Nakanishi M., Sato K., Mise K., Yamasaki S., Teramura Y., Ohgaki K. & Tobe T. (19901026). Therapeutic efficacy of sequential therapy with OK-432, cyclophosphamide, IL2-cultured lymphocytes and in vivo IL2 against advanced murine plasmacytoma. : Biotherapy (Dordrecht, Netherlands).

Chicago

Kan N, Okino T, Nakanishi M, Sato K, Mise K, Yamasaki S, Teramura Y, Ohgaki K and Tobe T. 19901026. Therapeutic efficacy of sequential therapy with OK-432, cyclophosphamide, IL2-cultured lymphocytes and in vivo IL2 against advanced murine plasmacytoma. : Biotherapy (Dordrecht, Netherlands).

Harvard

Kan N., Okino T., Nakanishi M., Sato K., Mise K., Yamasaki S., Teramura Y., Ohgaki K. and Tobe T. (19901026). Therapeutic efficacy of sequential therapy with OK-432, cyclophosphamide, IL2-cultured lymphocytes and in vivo IL2 against advanced murine plasmacytoma. : Biotherapy (Dordrecht, Netherlands).

MLA

Kan N, Okino T, Nakanishi M, Sato K, Mise K, Yamasaki S, Teramura Y, Ohgaki K and Tobe T. Therapeutic efficacy of sequential therapy with OK-432, cyclophosphamide, IL2-cultured lymphocytes and in vivo IL2 against advanced murine plasmacytoma. : Biotherapy (Dordrecht, Netherlands). 19901026.